Joint CPhA/APhA Statement - Drug Importation Policy
Thu, Feb 28, 2019
The associations’ top concerns center on patient safety and optimal medication use. When pharmacists dispense medications, they review and assess all available health information to ensure that medications are safe and appropriate for their patients. This includes identifying possible drug interactions and other adverse events and communicating and resolving any concerns with the patients’ prescribers.
Canadian pharmacies may only dispense medications prescribed by a Canadian prescriber. “This regulation is in place to protect the safety of patients by ensuring that physicians and pharmacists have established relationships with their patients and knowledge of their medical histories,” said CPhA CEO Glen Doucet. “Recently proposed personal drug importation policies pose additional challenges that have not been contemplated.” Read the full news release or the full joint statement.
Return to list
2019‐2020 Seasonal Influenza Immunization Program Participation
The Drug Plan and Extended Benefits Branch (DPEBB) is registering pharmacies that plan to participate in the Province’s 2019‐2020 Seasonal Influenza Immunization Program (the Program).More
Florinef Shortage Update
The Florinef shortage information is posted on behalf of medSask.More
Recently the Drug Plan and Extended Benefits Branch (DPEBB) sent out a communication about the SMAP audit done in February 2019. PAS wanted to follow up with some “quick tips” to assist with building on the improvement observed from previous audits.More
Congratulations Mike Stuber, Canadian Pharmacist of the Year!
Saskatchewan pharmacist, Mike Stuber, who specializes in HIV treatment and prevention is named the 2019 Canadian Pharmacist of the Year by CPhA.More